Ensuring Nationwide Access to a Better Life Experience Act or the ENABLE Act This bill makes permanent three tax provisions relating to ABLE (Achieving a Better Life Experience) Accounts established to assist disabled individuals, specifically provisions allowing increased contributions to such accounts, the allowance of a retirement savings contribution tax credit up to $1,000, and allowing a tax-free rollover from a qualified tuition (529 plan) to an ABLE account.
HR 8673 establishes the Foundation for Standards and Metrology, a nonprofit entity to support the National Institute of Standards and Technology (NIST) in advancing measurement science, technical standards, and technology development. The Foundation will foster collaboration between NIST, researchers, industry, educational institutions, and nonprofits to accelerate the commercialization of federally funded research and provide direct support like fellowships and grants to NIST associates. Governed by a Board of Directors and required to become financially self-sustaining within five years, the Foundation must submit annual reports to Congress detailing its activities, finances, and progress toward strategic goals. The bill authorizes $1.5 million annually for NIST to fund the Foundation’s operations from 2025 through 2029.
This concurrent resolution (HCONRES 113) is a symbolic congressional tribute honoring former President George H.W. Bush on the occasion of his 100th birthday. It recognizes his life, public service, and legacy without creating any new laws or affecting specific individuals or groups. The resolution formally acknowledges his career achievements, including his military service, presidency, and contributions to policy like the Americans with Disabilities Act, while expressing Congress's gratitude to him and his family. As a commemorative resolution, it has no binding effect or policy impact.
Senate Joint Resolution 96 seeks to block a Department of Education rule that prohibits sex-based discrimination in federally funded schools (e.g., colleges, K-12 programs receiving federal aid). If approved, it would invalidate the rule published April 29, 2024 (89 Fed. Reg. 33474), preventing it from taking effect under a congressional disapproval process. This would maintain existing nondiscrimination standards for education programs instead of implementing the new rule. The resolution directly affects all schools and programs receiving federal education funding.
The Dismantle DEI Act of 2024 would eliminate diversity, equity, and inclusion (DEI) programs across federal agencies by rescinding related executive orders, closing DEI offices, and prohibiting federal funding for DEI training and activities. The bill defines "prohibited diversity, equity, or inclusion practice" to include training that asserts certain racial or ethnic groups are inherently superior or inferior, and bans federal funds from being used for such programs. It would apply to federal offices, training, contracting, grants, advisory committees, and education programs, with enforcement through private lawsuits and penalties of $1,000 per violation per day. The bill specifically exempts Equal Employment Opportunity offices and offices enforcing the Americans with Disabilities Act from these restrictions.
This bill prohibits federal and state entities from penalizing health care organizations or providers who decline to participate in abortion services, referrals, coverage, or facilitation. It creates a private right of action, allowing affected individuals or entities to sue for violations in federal court and seek remedies like injunctions or damages. The law covers hospitals, insurers, pharmacies, clinics, and other health care entities, ensuring they can maintain conscience-based objections without losing federal funding or facing retaliation. Enforcement would be handled by the Office for Civil Rights, which must investigate complaints and refer cases to the Justice Department when needed.
This bill amends the International Religious Freedom Act and Foreign Assistance Act to restrict U.S. foreign aid funding for non-theist groups. It requires that U.S. diplomatic missions ensure foreign aid programs do not promote non-theist ideologies or expand non-theist group membership, and mandates proportional funding to religious groups if non-theist groups receive support. The bill also requires annual reports listing all grants to religious, atheist, agnostic, and humanist groups worldwide, including funding details and compliance with constitutional religious freedom principles. These changes directly affect U.S. diplomatic missions and foreign organizations receiving U.S. government aid.
This bill extends the planning cycle for workforce development programs under the Workforce Innovation and Opportunity Act (WIOA) from 4 years to 5 years. It directly affects state workforce boards, local workforce development boards, and programs serving migrant and seasonal farmworkers by modifying their planning and reporting requirements. Key provisions adjust timeframes throughout the law, such as changing "4-year" to "5-year" for state plans, local plans, and performance accountability periods, while maintaining flexibility for states to use either 4- or 5-year cycles as appropriate.
The WIOA Performance Accountability Improvement Act amends the federal Workforce Innovation and Opportunity Act to strengthen how states and local areas measure and report on workforce development program outcomes. It updates performance metrics to focus more on job retention and earnings gains after training, requires standardized reporting of new data elements like cost-to-earnings ratios and demographic information, and establishes tiered sanctions for states that consistently fail to meet performance targets. This affects all states and local workforce boards administering WIOA programs, as well as the training providers delivering services through these programs. The bill aims to make workforce development more effective by using clearer performance data and stronger accountability measures.
This bill delays a Medicare policy that would have restricted oral medications for managing phosphate levels in end-stage renal disease (ESRD) patients. It extends the implementation deadline from January 1, 2025, to January 1, 2027, for the policy affecting drugs used to control serum phosphate. The bill also requires the Health Secretary to study Medicare coverage gaps, costs, patient adherence (measured via phosphate levels), and adverse events related to these medications. The study will examine data from 2022-2024 and propose strategies to improve adherence and reduce costs for ESRD patients enrolled in Medicare Part D or Medicare Advantage plans.
HR 8693, the "No American Land for Communist China Act," prohibits U.S. citizens or entities from purchasing real estate adjacent to specific federal lands if owned by the Chinese government or businesses with 25%+ Chinese government ownership. It directly affects Chinese government entities and Chinese-owned businesses operating in the U.S., restricting their ability to buy land near protected federal areas. The bill requires the President to take necessary actions to block such purchases, covering lands managed by Interior, Defense, Agriculture (Forest Service), or designated Indian country. This is a policy restriction, not a funding measure, targeting land transactions near sensitive federal properties.
This resolution (HRES 1285) is a symbolic statement by a group of House members condemning the Biden administration's approach to mifepristone (the abortion pill), specifically the 2023 FDA decision allowing mail-order and pharmacy dispensing of the drug without in-person provider visits. It argues this policy eliminates safety safeguards like in-person ultrasounds to detect ectopic pregnancies, gestational age checks, and provider screening for coercion, potentially increasing health risks for patients. The resolution does not change any laws or policies but expresses disapproval of the FDA’s regulatory changes regarding mifepristone distribution. As a non-binding resolution, it has no legal effect on abortion access or drug regulations.
